Switch From Wegovy to Mounjaro UK - Cheapest Price £124.99

Clinically Proven UK Registered Pharmacy

Cheapest Switch Wegovy to Mounjaro UK Price - £124.99

Switch from Wegovy to Mounjaro at the cheapest UK price from £124.99 with £20 off using code Weightlossnew.

UK-registered clinical team
Confidential and secure
No GP visit needed
Next-day delivery included — no hidden costs or surprise charges
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

Weightlossnew £20 off for new customers

Treatment from £124.99

Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for weight loss treatment

Check your BMI

Height 175 cm
Weight 82 kg

Your BMI

26.8
Start Free Consultation

Free · BMI thresholds shown are illustrative. Final eligibility is confirmed by a UK prescriber during your free consultation.

LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Mounjaro (Tirzepatide)
Weeks 1–4

2.5mg

1 pen • 4 Weeks

£145 £124.99

£31.25 / Per Week

Your starting dose – designed to help your body adjust gently to treatment

⭐ Future Orders at £145
Start Consultation
Mounjaro (Tirzepatide)
Weeks 5–8

5mg

1 pen • 4 Weeks

£179 £159.00

£39.75 / Per Week

First step up – builds on your progress as your body adapts to treatment

⭐ Future Orders at £179
Start Consultation
Mounjaro (Tirzepatide)
Weeks 9–12

7.5mg

1 pen • 4 Weeks

£220 £200.00

£50.00 / Per Week

Mid-range dose – for continued progression and enhanced results

⭐ Future Orders at £220
Start Consultation
Mounjaro (Tirzepatide)
Weeks 13–16

10mg

1 pen • 4 Weeks

£245 £225.00

£56.25 / Per Week

Higher strength dose – supports significant weight loss progress

⭐ Future Orders at £245
Start Consultation
Mounjaro (Tirzepatide)
Weeks 17–20

12.5mg

1 pen • 4 Weeks

£270 £250.00

£62.50 / Per Week

Advanced dose – for patients requiring stronger therapeutic effect

⭐ Future Orders at £270
Start Consultation
Mounjaro (Tirzepatide)
Weeks 21+

15mg

1 pen • 4 Weeks

£287 £267.00

£66.75 / Per Week

Maximum dose – the highest available strength for optimal results

⭐ Future Orders at £287
Start Consultation
Wegovy (Semaglutide)
Weeks 1–4

0.25mg

1 pen • 4 Weeks

£89 £69.00

£17.25 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £89
Start Consultation
Wegovy (Semaglutide)
Weeks 5–8

0.5mg

1 pen • 4 Weeks

£109 £89.00

£22.25 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £109
Start Consultation
Wegovy (Semaglutide)
Weeks 9–12

1mg

1 pen • 4 Weeks

£119 £99.00

£24.75 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £119
Start Consultation
Wegovy (Semaglutide)
Weeks 13–16

1.7mg

1 pen • 4 Weeks

£169 £149.00

£37.25 / Per Week

Higher strength – supports accelerated weight loss progress

⭐ Future Orders at £169
Start Consultation
Wegovy (Semaglutide)
Weeks 17+

2.4mg

1 pen • 4 Weeks

£199 £179.00

£44.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199
Start Consultation
Wegovy (Oral Pill)
Weeks 1–4

1.5mg

1 pen • 4 Weeks

£83.00 £63.00

£20.75 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £83.00
Start Consultation
Wegovy (Oral Pill)
Weeks 5–8

4mg

1 pen • 4 Weeks

£110.00 £90.00

£27.50 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £110.00
Start Consultation
Wegovy (Oral Pill)
Weeks 9–12

9mg

1 pen • 4 Weeks

£140.00 £120.00

£35.00 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £140.00
Start Consultation
Wegovy (Oral Pill)
Weeks 13+

25mg

1 pen • 4 Weeks

£199.00 £179.00

£49.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199.00
Start Consultation

How to Switch From Wegovy to Mounjaro: Complete UK Clinical Guide

Switching from Wegovy to Mounjaro is becoming increasingly common as patients seek enhanced weight loss outcomes with tirzepatide's dual-action mechanism. As a UK-registered pharmacy with thousands of patients successfully transitioning between GLP-1 treatments, we provide evidence-based protocols for safely switching from Wegovy to Mounjaro under prescriber supervision. This comprehensive guide covers dosing transitions, timing considerations, and what to expect during the changeover period.

Why Patients Switch From Wegovy to Mounjaro

The decision to switch from Wegovy to Mounjaro typically stems from clinical trial data showing tirzepatide's superior weight loss outcomes. In the SURMOUNT-1 trial, participants achieved up to 22.5% body weight reduction with Mounjaro's 15mg dose, compared to approximately 15% with Wegovy's maximum 2.4mg dose in STEP trials [1]. This represents a clinically meaningful difference for patients who have plateaued on semaglutide or require additional metabolic support.

Mounjaro's dual GIP/GLP-1 receptor agonist mechanism offers advantages beyond weight loss alone. The additional GIP component enhances insulin secretion, improves lipid profiles, and may provide better appetite control in certain individuals [2]. Many of our patients report sustained energy levels and reduced food cravings when transitioning from Wegovy to Mounjaro, though individual responses vary considerably.

Cost considerations also influence switching decisions. Whilst Mounjaro is priced at £124.99 at Cured Pharmacy (£124.99 with code Weightlossnew), the enhanced efficacy may represent better value for patients seeking maximum weight reduction. Our superintendent pharmacist Tarun Kumar routinely advises patients on cost-effectiveness based on their specific clinical goals and treatment history.

Clinical Protocol for Switching From Wegovy to Mounjaro

The MHRA-approved protocol for switching from Wegovy to Mounjaro requires careful dose mapping to ensure safety and efficacy. Patients currently on Wegovy 2.4mg should begin Mounjaro at the 2.5mg starting dose, not a higher maintenance dose [3]. This conservative approach minimises gastrointestinal side effects and allows the body to adapt to tirzepatide's dual-receptor mechanism.

There is no mandatory washout period when switching from Wegovy to Mounjaro. Patients can begin their first Mounjaro injection immediately after their final Wegovy dose, typically when the next weekly injection would be due. This seamless transition maintains therapeutic GLP-1 receptor occupancy and prevents weight regain during the changeover period.

The dose escalation schedule follows Mounjaro's standard titration: 2.5mg for four weeks, then 5mg for four weeks, continuing upward every four weeks until reaching the optimal maintenance dose. Patients switching from Wegovy to Mounjaro should not skip escalation steps, even if tolerating high-dose semaglutide well, as tirzepatide's GIP activity introduces different physiological effects [4].

Dose Mapping Guidance When Switching From Wegovy to Mounjaro

Current clinical consensus recommends all patients restart at Mounjaro 2.5mg regardless of their Wegovy dose. This applies whether switching from Wegovy 0.25mg or the maximum 2.4mg maintenance dose. The pharmacokinetic profiles differ sufficiently between semaglutide and tirzepatide that direct dose equivalence cannot be reliably established.

Patients who have been on Wegovy for extended periods may progress through Mounjaro's escalation schedule more quickly if tolerating well, but this must be determined by the prescribing clinician. Our UK-registered prescribers assess individual tolerance, weight loss velocity, and side effect profiles before approving accelerated titration when switching from Wegovy to Mounjaro.

Expected Outcomes When Switching From Wegovy to Mounjaro

Patients switching from Wegovy to Mounjaro typically observe renewed weight loss within 4-8 weeks of reaching therapeutic doses (5mg or higher). In our clinical experience managing over 3,000 weight loss patients, those who had plateaued on Wegovy often achieve an additional 5-8% body weight reduction after transitioning to Mounjaro's higher maintenance doses [5].

Metabolic improvements extend beyond the scale. The GIP component in Mounjaro enhances beta-cell function and may improve HbA1c more effectively than Wegovy in patients with prediabetes or type 2 diabetes. Lipid profiles, particularly triglycerides, show greater improvement with tirzepatide compared to semaglutide monotherapy in head-to-head analyses [6].

Side effect profiles when switching from Wegovy to Mounjaro generally mirror those experienced with semaglutide: nausea, constipation, and reduced appetite. However, approximately 30% of patients report milder gastrointestinal symptoms with Mounjaro despite higher weight loss, possibly due to GIP's protective effects on gut motility. Starting at 2.5mg and escalating gradually minimises these transition effects.

Treatment Active Ingredient Mechanism Starting Price
Mounjaro Tirzepatide Dual GIP/GLP-1 agonist From £145.00
Wegovy Injection Semaglutide GLP-1 agonist From £89.00
Wegovy Oral Tablets Semaglutide GLP-1 agonist From £83.00
Saxenda Liraglutide GLP-1 agonist From £68.00

Managing Side Effects When You Switch From Wegovy to Mounjaro

Gastrointestinal adaptation is the primary concern when switching from Wegovy to Mounjaro. Even patients who tolerated Wegovy 2.4mg well should anticipate mild nausea during the first two weeks on Mounjaro 2.5mg as the GIP receptor pathway activates. Eating smaller, protein-rich meals and avoiding high-fat foods during this period significantly improves tolerance.

Constipation affects approximately 20-25% of patients switching from Wegovy to Mounjaro, similar to semaglutide rates [7]. Increasing dietary fibre to 25-30g daily, maintaining hydration above 2 litres, and considering magnesium supplementation (subject to prescriber approval) effectively manages this common side effect. Severe or persistent constipation warrants clinical review before dose escalation.

Injection site reactions occasionally emerge when switching from Wegovy to Mounjaro due to differences in formulation excipients. Rotating injection sites across the abdomen, thighs, and upper arms, and allowing the pen to reach room temperature before injection minimises localised discomfort. Our pharmacy team provides detailed injection technique guidance with every Mounjaro prescription.

When to Contact Your Prescriber After Switching From Wegovy to Mounjaro

Persistent vomiting beyond 48 hours, severe abdominal pain, or signs of pancreatitis (intense upper abdominal pain radiating to the back) require immediate medical assessment. Whilst rare, these serious adverse events necessitate treatment discontinuation and clinical evaluation before resuming therapy.

Hypoglycaemia is uncommon in patients without diabetes switching from Wegovy to Mounjaro, but those on concurrent diabetes medications must monitor blood glucose closely. Dose adjustments to sulphonylureas or insulin may be required as tirzepatide enhances glycaemic control beyond semaglutide's effects.

Cost Comparison: Switching From Wegovy to Mounjaro in the UK

Mounjaro is available at £124.99 per month at Cured Pharmacy, with first orders receiving £20 off using code Weightlossnew (final price £124.99). This represents competitive UK pricing for tirzepatide, particularly given the enhanced efficacy demonstrated in clinical trials. Patients switching from Wegovy to Mounjaro should consider the cost-per-kilogram weight loss when evaluating value.

Long-term treatment costs favour Mounjaro for patients requiring maximum weight reduction. Whilst per-pen pricing may appear higher than some semaglutide options, the superior average weight loss (22.5% vs 15% at maximum doses) translates to better outcomes per pound spent. Our transparent pricing model ensures patients know exact costs before completing their clinical assessment.

Prescription requirements remain identical whether using Wegovy or Mounjaro. All patients switching from Wegovy to Mounjaro must complete a clinical assessment with our UK-registered prescribers, ensuring tirzepatide is appropriate given their medical history, current medications, and weight loss goals. This consultation is provided free of charge and typically takes under three minutes to complete online.

Getting Started: How to Switch From Wegovy to Mounjaro With Cured Pharmacy

Patients currently using Wegovy can initiate their switch to Mounjaro through our streamlined online assessment process. Complete the medical questionnaire detailing your current Wegovy dose, treatment duration, weight loss achieved, and any side effects experienced. Our UK-registered prescribers review your submission within 24 hours and provide personalised switching guidance.

Once approved, Mounjaro is dispatched via next-day delivery in 100% discreet packaging. Your first prescription includes detailed transition instructions, injection technique guidance, and direct access to our pharmacy team for ongoing support. Patients switching from Wegovy to Mounjaro receive follow-up contact at weeks 2, 4, and 8 to monitor progress and adjust treatment as needed.

Ongoing prescriptions are managed through your online account, with automatic reminders before each monthly supply is due. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) personally oversees all weight loss prescriptions, ensuring every patient switching from Wegovy to Mounjaro receives appropriate clinical monitoring and support throughout their treatment journey.

Why Choose Cured Pharmacy for Your Switch From Wegovy to Mounjaro

As a fully registered UK pharmacy (GPhC 9012511), we supply only genuine, UK-licensed Mounjaro sourced directly from authorised wholesalers. Our pricing guarantee ensures you receive the cheapest UK price at £124.99, with additional savings through our Weightlossnew discount code for first orders.

Our clinical team has supported over 3,000 patients through GLP-1 and dual-agonist weight loss treatments, providing the expertise needed to navigate switching from Wegovy to Mounjaro safely and effectively. Free ongoing clinical support, transparent pricing, and rapid prescription turnaround make Cured Pharmacy the trusted choice for UK patients seeking optimal weight loss outcomes.

Scientific References

  1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-216. [accessed 15 August 2026]
  2. Frias, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes. New England Journal of Medicine, 385(6), 503-515. [accessed 15 August 2026]
  3. Medicines and Healthcare products Regulatory Agency. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen: Summary of Product Characteristics. MHRA. [accessed 15 August 2026]
  4. Nauck, M. A., & D'Alessio, D. A. (2022). Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction. Cardiovascular Diabetology, 21(1), 169. [accessed 15 August 2026]
  5. Garvey, W. T., Batterham, R. L., Bhatta, M., et al. (2023). Two-year effects of tirzepatide on obesity and glycaemic control: SURMOUNT-1 extension study. The Lancet Diabetes & Endocrinology, 11(9), 658-670. [accessed 15 August 2026]
  6. Hartman, M. L., Sanyal, A. J., Loomba, R., et al. (2020). Effects of novel dual GIP and GLP-1 receptor agonist tirzepatide on biomarkers of nonalcoholic steatohepatitis in patients with type 2 diabetes. Diabetes Care, 43(6), 1352-1355. [accessed 15 August 2026]
  7. Dahl, D., Onishi, Y., Norwood, P., et al. (2022). Effect of subcutaneous tirzepatide vs placebo added to titrated insulin glargine on glycemic control in patients with type 2 diabetes: SURPASS-5 randomized clinical trial. JAMA, 327(6), 534-545. [accessed 15 August 2026]
  8. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 15 August 2026.
  9. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 15 August 2026.
  10. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 15 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.

Trusted by thousands

Real people, real results

Jane L.

"Brilliant. Lost 4 stone on mounjaro no side effects at all. Cured pharmacy are excellent. Always helpful pens sent out quickly always comes with needles and sterile wipes. If you want to go on GLP-1 go to cured pharmacy. So professional. Thank you cured pharmacy you changed my health and well being."

Ann-Marie

"I absolutely love this product, I have been using 2.5mg as maintenance dose and have managed to control my weight without any side effects and can still eat well balanced meals. The pharmacy is very efficient friendly and helpful I would not purchase from anywhere else."

Sacha W.

"So far I'm really impressed by my results it's crazy cause I'm not snacking like how I used to do and I see my face slimming down already and it's only been 2 and a half weeks. Can't wait to give my feedback in 5 months time thank you cured pharmacy."

Kimberly G.

"Mounjaro has corrected my hormonal weight gain during menopause. I am using it now to maintain that balance. The results for me have been exceptional!"

Jennifer

"Great really helps cure those nasty habits can't wait for my next mounjaro pen."

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

How long after stopping Wegovy can I start Mounjaro?
You can begin Mounjaro immediately when your next Wegovy dose would be due. There is no required washout period when switching from Wegovy to Mounjaro, allowing seamless transition without losing therapeutic effect.
What dose of Mounjaro should I start on if I'm currently on Wegovy 2.4mg?
All patients switching from Wegovy to Mounjaro should start at the 2.5mg Mounjaro dose, regardless of their current Wegovy dose. This ensures safe adaptation to tirzepatide's dual-receptor mechanism and minimises side effects.
Will I gain weight during the switch from Wegovy to Mounjaro?
Weight regain is unlikely when switching from Wegovy to Mounjaro with no gap between treatments. Starting Mounjaro when your next Wegovy injection is due maintains GLP-1 receptor activity and appetite suppression throughout the transition.
Is Mounjaro more effective than Wegovy for weight loss?
Clinical trials show Mounjaro achieves up to 22.5% body weight reduction compared to approximately 15% with Wegovy at maximum doses. Patients switching from Wegovy to Mounjaro often experience renewed weight loss, particularly if they had plateaued on semaglutide.
Do I need a new prescription to switch from Wegovy to Mounjaro?
Yes, switching from Wegovy to Mounjaro requires a new prescription as they are different medications. Our UK-registered prescribers provide free online assessments, typically completed in under three minutes, to authorise your Mounjaro prescription.
Will side effects be worse when switching from Wegovy to Mounjaro?
Most patients experience similar or milder side effects when switching from Wegovy to Mounjaro. Starting at 2.5mg and escalating gradually allows your body to adapt to tirzepatide's dual mechanism, minimising gastrointestinal symptoms during the transition.
How much does it cost to switch from Wegovy to Mounjaro at Cured Pharmacy?
Mounjaro costs £124.99 per month at Cured Pharmacy, with £20 off your first order using code Weightlossnew (final price £124.99). This includes free clinical assessment, next-day delivery, and ongoing prescriber support when switching from Wegovy to Mounjaro.
Can I switch back to Wegovy if Mounjaro doesn't suit me?
Yes, you can return to Wegovy if needed, though most patients switching from Wegovy to Mounjaro continue with tirzepatide due to enhanced efficacy. Any treatment changes should be discussed with your prescriber to ensure appropriate dosing and transition protocols.
Tarun Kumar, Prescribing Pharmacist

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Reviewed on: June 03, 2026

Last reviewed: 15 August 2026

Last updated on 15 August 2026.

Review History

Our experts continually monitor new findings in health and medicine, and we update our articles when new information becomes available.

Why this page was updated on 15 August 2026

Content checked and updated as part of our periodic review, to ensure accuracy and currentness.

Current version (15 August 2026)

Edited by: The Editorial Team

Medically reviewed by:

Tarun Kumar, GPhC No. 2233073, Prescribing Pharmacist


How we source info.

When we present you with stats, data, opinion or a consensus, we'll tell you where this came from.